Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic Acid for NNT Mutation-Related Glucocorticoid Deficiency
NCT02838472Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Jun 2016
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ascorbic acid in primary adrenal insufficiency (PAI), sponsored by Hadassah Medical Organization. Primary endpoints: Glucocorticoids secretion in response to ACTH test at 1 year and Basal ACTH levels at 1 year. Status: unknown.
02
Drugs
ascorbic acid
03
Conditions
primary adrenal insufficiency (PAI)
Beyond the preview
Go deeper on NCT02838472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02838472.